How a Swedish startup caught Bryan Johnson's attention - Episode #9 with Maria Rankka
LEVITY1 Okt 2024

How a Swedish startup caught Bryan Johnson's attention - Episode #9 with Maria Rankka

🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership#mobilize-sign-up


🚀 Show notes for this episode will be available Wednesday Oct 2. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/


Longevity superstar Bryan Johnson made waves when he traveled to the Bahamas for a stem cell treatment. But who's behind this cutting-edge therapy? Meet Maria Rankka, co-founder of Cellcolabs, the Swedish startup that's caught the attention of one of the world's biggest longevity influencers.

In this episode of LEVITY, hosts Peter Ottsjö and Patrick Linden dive deep into Cellcolabs' ambitious mission: to revolutionize healthcare by producing cheap and abundant mesenchymal stromal cells (MSCs). Could this be the key to combating inflammation and extending healthspan on a global scale?

Maria Rankka shares the inside story of Cellcolabs' journey, from its inception during the COVID-19 pandemic to its current position at the forefront of regenerative medicine.


Learn about:

✅ The science behind MSCs and why they're creating buzz in longevity circles

✅ Cellcolabs' innovative approach to scaling stem cell production

✅ Maria's personal experience with MSC treatment

✅ The potential of MSCs to transform preventative medicine

✅ Making regenerative treatments accessible to the masses

🗞️ SUBSCRIBE to the LEVITY newsletter: reachlevity.com/subscribe

Get all LEVITY DeSci content here: reachlevity.com/t/desci (sorry about the wrong link in the episode)


📕 Check out Patrick's book: https://mitpress.mit.edu/9780262543163/the-case-against-death/

📗 Check out Peter's book (only available in Swedish): https://www.adlibris.com/sv/bok/evigt-ung-min-och-manniskans-drom-om-ododligheten-9789179652524


-----


Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: reachlevity.com/subscribe


LEVITY is co-hosted by Patrick Linden, philosopher and author, and Peter Ottsjö, journalist and author.

Hosted on Acast. See acast.com/privacy for more information.

Episoder(39)

#37 The Anti-Catastrophe League

#37 The Anti-Catastrophe League

Tom Ough tells us about the Big Things that may end humanity - and what we can do and in some cases have done to prevent these. Did you know that if all the risks, the one that is most likely to end y...

16 Des 202544min

#36 How crypto is sparking a longevity frenzy

#36 How crypto is sparking a longevity frenzy

Today we’re diving into one of the strangest and most ambitious ideas in longevity: using crypto trading to fund real-time lifespan experiments.Benji Leibowitz, founder of pump.science, joins us to ex...

2 Des 20251h 48min

#35 The Anti-Aging Uprising: Felix Werth’s Political Attack on Death Itself

#35 The Anti-Aging Uprising: Felix Werth’s Political Attack on Death Itself

Valuable time is being lost because there is not enough funding for science with real life-extending potential. No major political party is promising to address aging, even though aging harms and kill...

11 Nov 20251h 24min

#34 Biomarkers of aging: How close are we, really? - A conversation with Sara Hägg

#34 Biomarkers of aging: How close are we, really? - A conversation with Sara Hägg

Sara Hägg, PhD is an associate professor at Karolinska Institutet, where she leads the Molecular Epidemiology of Aging Group. Her work focuses on human biomarkers of aging - especially biological age ...

28 Okt 20251h 36min

#33 “Can death be the answer?"  A conversation with philosopher Nicholas Agar

#33 “Can death be the answer?" A conversation with philosopher Nicholas Agar

We are always excited about the next technological solution. But what if it does not come? Or what if it comes only for the few, or with terrible side-effects? And while we are waiting for the easy te...

7 Okt 20251h 44min

#32 “Medical malpractice”: Matt Kaeberlein on biological age tests

#32 “Medical malpractice”: Matt Kaeberlein on biological age tests

One idea I’ve had lately is to put together a list of people to trust in geroscience and the longevity field more broadly. (And I might do it - keep an eye on reachlevity.com- and subscribe while you’...

23 Sep 20251h 50min

# 31 He wants to save your pet with cryo - The Kai Micah Mills interview

# 31 He wants to save your pet with cryo - The Kai Micah Mills interview

When you give a child a pet, you also expose them to death—since most pets pass away long before their owners. But what if we could cryopreserve Buddy or Tiger, and bring them back from suspended anim...

9 Sep 20252h 8min

#30 Soon you'll take a drug designed by AI  | Alex Zhavoronkov

#30 Soon you'll take a drug designed by AI | Alex Zhavoronkov

As you may have heard, AI-designed medicines have crossed a historic line. In this episode, Alex Zhavoronkov - CEO of Insilico Medicine and founder of ARDD walks us through how Insilico’s rentosertib ...

26 Aug 20252h 13min

Populært innen Vitenskap

fastlegen
rekommandert
tingenes-tilstand
jss
forskningno
sinnsyn
liberal-halvtime
rss-rekommandert
tomprat-med-gunnar-tjomlid
smart-forklart
rss-paradigmepodden
villmarksliv
fjellsportpodden
tidlose-historier
dekodet-2
vett-og-vitenskap-med-gaute-einevoll
nordnorsk-historie
diagnose
abid-nadia-skyld-og-skam
rss-overskuddsliv